Effects of metformin administration on plasma gonadotropin levels in women with infertility, with an in vitro study of the direct effects on the pituitary gonadotrophs

Pituitary

Volumn 13, Issue 3, 2010, Pages 236-241

  Oride, Aki ^a   Kanasaki, Haruhiko ^a   Purwana, Indri N ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

FSH; LH; Metformin; PCOS

Indexed keywords

FOLLITROPIN; FOLLITROPIN BETA SUBUNIT; GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE BETA SUBUNIT; METFORMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION REGULATION; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN SECRETING CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PATIENT CODING; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; CELL LINE; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPHS; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; METFORMIN; POLYCYSTIC OVARY SYNDROME; PROMOTER REGIONS, GENETIC;

EID: 77955927305     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-010-0223-x     Document Type: Article

References (22)

1. MO Goodarzi R Azziz 2006 Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome Best Pract Res Clin Endocrinol Metab 20 193 205 10.1016/j.beem.2006.02.005 1:CAS:528:DC%2BD28Xls1aqtbk%3D 16772151 (Pubitemid 43842923)
2. E Hughes J Collins P Vandekerckhove 2000 Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea Cochrane Database Syst Rev 3 CD000056
3. GA Burghen JR Givens AE Kitabchi 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metab 50 113 116 10.1210/jcem-50-1-113 1:STN:280:DyaL3c%2Fnt1eltA%3D%3D 7350174
4. LF Santana MF de Sa RA Ferriani, et al. 2004 Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome Gynecol Endocrinol 19 88 96 10.1080/09513590400002342 1:CAS:528: DC%2BD2cXnslSntbk%3D 15624270 (Pubitemid 39331409)
5. HJ Thierry van Dessel PD Lee G Faessen BC Fauser LC Giudice 1999 Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome J Clin Endocrinol Metab 84 3030 3035 10.1210/jc.84.9.3030 1:STN:280: DyaK1MvhsFKjsw%3D%3D 10487660
6. AA Creanga HM Bradley C McCormick CT Witkop 2008 Use of metformin in polycystic ovary syndrome: a meta-analysis Obstet Gynecol 111 959 968 1:CAS:528:DC%2BD1cXkvVaktbg%3D 18378757
7. LG Nardo R Rai 2001 Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects Gynecol Endocrinol 15 373 380 1:CAS:528:DC%2BD38Xks1ahtQ%3D%3D 11727360
8. RL Barbieri A Makris RW Randall, et al. 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism J Clin Endocrinol Metab 62 904 910 10.1210/jcem-62-5-904 1:STN:280:DyaL287mvVOgug%3D%3D 3514651
9. RA DeFronzo AM Goodman 1995 Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The multicenter metformin study group N Engl J Med 333 541 549 10.1056/NEJM199508313330902 1:CAS:528:DyaK2MXpsVanurY%3D 7623902
10. R Mansfield R Galea M Brincat D Hole H Mason 2003 Metformin has direct effects on human ovarian steroidogenesis Fertil Steril 79 956 962 10.1016/S0015-0282(02)04925-7 12749437 (Pubitemid 36385020)
11. AD Genazzani C Battaglia B Malavasi, et al. 2004 Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome Fertil Steril 81 114 119 10.1016/j.fertnstert.2003.05.020 1:CAS:528: DC%2BD2MXitFCrs7c%3D 14711553 (Pubitemid 38058335)
12. UB Kaiser E Sabbagh RA Katzenellenbogen PM Conn WW Chin 1995 A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone Proc Natl Acad Sci USA 92 12280 12284 10.1073/pnas.92.26.12280 1:CAS:528:DyaK28Xhtl2nsQ%3D%3D 8618885 (Pubitemid 26014054)
13. GY Bedecarrats UB Kaiser 2003 Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused L beta T2 cells: role of GnRH receptor concentration Endocrinology 144 1802 1811 10.1210/en.2002-221140 1:CAS:528: DC%2BD3sXjt1Wis7Y%3D 12697686 (Pubitemid 36543318)
14. EY Adashi CE Resnick AJ D'Ercole ME Svoboda JJ Van Wyk 1985 Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function Endocr Rev 6 400 420 10.1210/edrv-6-3-400 1:CAS:528:DyaL2MXlvV2qsbo%3D 2992919
15. JE Nestler LP Powers DW Matt, et al. 1991 A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome J Clin Endocrinol Metab 72 83 89 10.1210/jcem-72-1-83 1:STN:280:DyaK3M%2FptleqsA%3D%3D 1898744
16. CJ Dunn DH Peters 1995 Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus Drugs 49 721 749 10.2165/00003495-199549050-00007 1:CAS:528:DyaK2MXlvVKku78%3D 7601013
17. EM Velazquez S Mendoza T Hamer F Sosa CJ Glueck 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 647 654 10.1016/0026-0495(94)90209-7 1:STN:280:DyaK2c3jtF2kuw%3D%3D 8177055 (Pubitemid 24145474)
18. P Moghetti R Castello C Negri, et al. 2000 Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation J Clin Endocrinol Metab 85 139 146 10.1210/jc.85.1.139 1:CAS:528:DC%2BD3cXjtl2huw%3D%3D 10634377 (Pubitemid 32268804)
19. ET Alarid JJ Windle DB Whyte PL Mellon 1996 Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice Development 122 3319 3329 1:CAS:528:DyaK28Xms1ymtLc%3D 8898243
20. T Harada H Kanasaki S Mutiara A Oride K Miyazaki 2007 Cyclic adenosine 3′, 5′monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells Biol Reprod 77 707 716 10.1095/biolreprod. 107.060327 1:CAS:528:DC%2BD2sXhtFahsb3J 17596563 (Pubitemid 47494386)
21. SJ Winters JP Moore 2007 Paracrine control of gonadotrophs Semin Reprod Med 25 379 387 10.1055/s-2007-984744 1:CAS:528:DC%2BD2sXhtVyns7rM 17710734 (Pubitemid 47339161)
22. S Rice L Pellatt K Ramanathan SA Whitehead HD Mason 2009 Metformin inhibits aromatase via an ERK (extracellular signal-regulated kinase)-mediated pathway Endocrinology 150 4794 4801 10.1210/en.2009-0540 1:CAS:528: DC%2BD1MXht1OktrjN 19574398